Last A$0.02 AUD
Change Today 0.00 / 0.00%
Volume 869.1K
ACU On Other Exchanges
As of 11:34 PM 02/26/15 All times are local (Market data is delayed by at least 15 minutes).

acuvax ltd (ACU) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/20/15 - A$0.03
52 Week Low
02/12/15 - A$0.02
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ACUVAX LTD (ACU)

Related News

No related news articles were found.

acuvax ltd (ACU) Related Businessweek News

No Related Businessweek News Found

acuvax ltd (ACU) Details

Acuvax Limited primarily researches and develops cancer therapies in Australia. It is also involved in the development of viruses and vaccines. The company is based in West Perth, Australia.

acuvax ltd (ACU) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

acuvax ltd (ACU) Key Developments

Acuvax Limited, Annual General Meeting, Feb 09, 2015

Acuvax Limited, Annual General Meeting, Feb 09, 2015., at 10:00 W. Australia Standard Time. Location: Suite 4, 16 Ord Street. Agenda: To approve the ratification of prior placement; to consider consolidation of capital; to consider ratification of issue of First Convertible Note (Maxim Convertible Note 1); to consider approval of issue of Second Convertible Note (Maxim Convertible Note 2); to consider approval of placement of shares; and to consider approval of placement of options.

Acuvax Limited Announces Loan Facility Extension

Acuvax Limited announced that it is completing a funding arrangement with a private equity investor syndicate to provide additional working capital. The funds raised total $250,000 and under the terms of the facility, the loan is repayable 12 months from the date of issue and at a coupon rate of 12%.

Acuvax Limited Announces the Resignation of Nigel Lee from the Board of the Company

The Board of Acuvax Limited announced that Mr. Nigel Lee has resigned from the Board of the company due to restrictions in place from his previous overseas employer. The board announced that Mr. Nigel Lee will now serve as chairman of the international advisory board assisting the company to develop strategy and establish new partnerships in global markets. One of Mr. Nigel Lee's first tasks will be to expand the advisory board and introduce suitable candidates to assist him with the advisory board's objectives.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACU:AU A$0.02 AUD 0.00

ACU Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ACU.
View Industry Companies

Industry Analysis


Industry Average

Valuation ACU Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 451.8x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 394.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACUVAX LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at